SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-131541
Filing Date
2016-07-07
Accepted
2016-07-07 16:17:30
Documents
3
Period of Report
2016-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-14599_18k.htm 8-K 34652
2 EX-99.1 a16-14599_1ex99d1.htm EX-99.1 17749
3 GRAPHIC g145991mmi001.jpg GRAPHIC 2724
  Complete submission text file 0001104659-16-131541.txt   57575
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 161756765
SIC: 3841 Surgical & Medical Instruments & Apparatus